key: cord-0839246-cwmthj9w authors: Tehrani, Shabnam; Khabiri, Neda; Moradi, Hamideh; mosavat, mina sadat; khabiri, seyyed saeed title: Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad Hospital in Tehran and its relationship with disease severity and mortality date: 2021-01-26 journal: Clin Nutr ESPEN DOI: 10.1016/j.clnesp.2021.01.014 sha: 29d5972a4d7dcdc53e7143af14689cbaf2dde455 doc_id: 839246 cord_uid: cwmthj9w Background and aims Novel Coronavirus (COVID-19) first appeared in China in late 2019 which was rapidly spread worldwide. As the COVID-19 pandemic continues to spread, it is crucial to determine the prognostic factors contributing to the development of severe disease and higher mortality. Herein we aimed to evaluate the correlation between the severity and prognosis of patients with COVID 19 with serum 25(OH)D levels. Method This descriptive retrospective study was performed from March to April 2020 at a referral center for patients with COVID-19, Tehran, Iran. The data collection was performed by a checklist consisting of the demographic features and laboratory assessments consisted of serum 25(OH)D were evaluated and recorded. And investigate the relationship between serum 25(OH)D and clinical outcomes of patients. Result 205 patients with a mean age of 59.71 years were enrolled. Our findings did not reveal a significant difference in mean levels of vitamin between improved (34.09) and deceased patients (34.54). However, in patients with severe disease, there was a considerable difference in levels of vitamin D in improved and deceased patients (P.value: 0.021). According to our results, the mortality rate was slightly higher in men (odds ratio:2.2). Furthermore, the mean age (64.20 vs. 58.51) and the presence of at least two comorbidities (odds ratio: 2.40) were significantly higher in deceased patients. Conclusion In this study, we did not reveal a statistical difference in mean levels of vitamin D and the outcome of patients with COVID-19. We concluded that in patients with severe disease, vitamin D deficiency could affect the course of the disease and mortality, especially in comorbidity and older people. Province, China (3, 4) . The next efforts were given to the clinical, para-clinical characteristics of the disease and the therapeutic approaches (5) (6) (7) (8) . Although the major number of infected patients were asymptomatic or presented mild symptoms like fever and upper respiratory tract irritation, severe cases of infection can lead to pneumonia, acute respiratory distress syndrome (ARDS), septic shock, multiple organ failure, and eventually death. Additionally, there is evidence suggesting the non-respiratory complications of the virus as gastrointestinal, cardiovascular, and neurological involvement which could worsen the final prognosis (9, 10) It should be noted that, regardless of various promising repurposing therapies and extensive research to produce vaccines, COVID-19 infection, it is still a major global challenge affecting an increasing number of patients in the world which is expected to rise moreover with the ongoing epidemic as the restricted control measures as quarantine, travel restrictions and social distance is not enforceable in many countries (11) (12) (13) . Early studies report independent associations between low serum 25-hydroxyvitanim D and susceptibility to acute respiratory tract infections (14) Recent studies have found an association between vitamin D and COVID-19 severity and mortality which is postulated to be based on the anti-inflammatory effects of vitamin D by suppressing cytokine storm as a known pathogenic process of ARDS development (15) (16) (17) (18) . Little is known about the role of vitamin D in preventing COVID-19 infection and fatality and more evidence is needed to recommend vitamin D supplements in the treatment of COVID-19. Also, because of the prevalence of vitamin D deficiency in Iran, it is a crucial issue that needs to be addressed. (19) As there is still no strong evidence of the effect of vitamin D status in the course of the disease, herein we aimed to evaluate the correlation between the severity and prognosis of patients with COVID 19 with serum vitamin D levels. This descriptive retrospective study was performed from March to April 2020 at a referral center for patients with COVID-19, Tehran, Iran. The study was approved by the ethics committee of Shahid As this is a newly emerging pandemic pertained to COVID-19, we enrolled all patients admitted with a confirmed diagnosis of COVID-19 who fulfilled the inclusion criteria. COVID-19 was diagnosed based on the WHO interim guidance (21) . A confirmed case of COVID-19 was defined as a positive result on real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay of nasopharyngeal swab specimens or the chest computed tomography (CT). The inclusion criteria in our study were as follows: 1. age 18 years or older 2. presence of clinical symptoms leading to hospitalization regarding the national protocol which included patients with moderate and severe conditions (RR > 30 times/min, Oxygen saturation in room air, less than 93%, Partial pressure ratio of arterial oxygen to air pressure, concentration Inspired by oxygen,(PaO2 /FiO2)less than 300 mm Hg) (22) . 3. a positive test for the nucleotide acid of SARS-COV-2 in a Nasopharyngeal swab specimen by (RT-PCR) or chest CT scan compatible with COVID-19 patterns. Our criteria for considering COVID-19 patients were positive PCR and if negative, cases with Covid-19 symptoms and CT scan changes according to Covid-19 were regrading as Covid-19 patients. In the following, the data collection was performed by a checklist consisting of the demographic features like age, sex, past medical history (DM, HTN, CKD, COPD), clinical symptoms as fever, myalgias, coughs, dyspnea, vital sign such as temperature, pulse rate, respiratory rate, saturation, duration of hospitalization and clinical outcome. Additionally, laboratory assessments consisted of a complete blood count, C-reactive protein (CRP)(adult normal range: 0.08-3.1 mg/L), and serum 25(OH)D were evaluated and recorded. In this study, serum 25(OH)D were considered as "very low" below 10 ng/ml, "insufficient" at 10-30 ng/ml, "sufficient" at 30-100 ng/ml, and "toxic" above 100 ng /ml, respectively. Vitamin D deficiency is considered by most articles to be below 30 ng/dL (23) (24) (25) , but in some studies, under 10 ng/ml class as "very low", which is associated with cardiovascular disease (26, 27) and a significant predictor for community-acquired pneumonia(28), as well as lower bone mineral densitometry and T scores than those with insufficient or normal values (29) . Because of these systemic effects, in patients with vitamin D deficiency, less than 10 ng/dl was considered "very low".Severe COVID-19 is defined as dyspnea, a respiratory rate of 30 or more breaths per minute, a blood oxygen saturation of 93% or less, a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (Pao2: Fio2) of less than 300 mm Hg, or infiltrates in more than 50% of the lung field within 24 to 48 hours from the onset of symptoms. (30) Eventually, the statistical analysis was performed using IBM SPSS© software version 19.0. For statistical analysis of the variability and mean of the variables, two-sample-tests or Chi-square tests were performed. To investigate the relationship between serum level 25 (OH) D and clinical outcomes of patients, a multivariate logistic regression test was used. A two-side P-value <0.05 was considered statistically significant. Additionally, we Observed that 162 patients improved and 43 patients died. The mean duration of hospitalization was 9.75 ± 5.47 days. Our findings did not reveal a significant difference in mean levels of vitamin between improved (mean: 34.09± 24.51) and deceased patients (mean:34.54 ± 28.74) (P-value = 0.226). However, in patients with severe disease, there was a considerable difference in mean levels of vitamin D in improved patients (36.8±17.54) and deceased patients (31.04±22.61) (P.value: 0.021, CI 95% = 48.43-33.88)). Furthermore, we revealed that the mortality rate was more evident in patients with very low levels of vitamin D (36%). The summary of the association of vitamin D levels and mortality is brought in table 2. Eventually, we evaluated the other factors correlated with a higher mortality rate. According to our results, the mortality rate was slightly higher in men (odds ratio:2.2 (P.value= 0.034, CI 95% = 1.72-2.54)). Furthermore, the mean age (64.20 vs. 58.51 with P.value= 0.014, CI 95% = 76.72-59. 23 ) and presence of At least two comorbidities (including diabetes mellitus, hypertension, ischemic heart disease, cancer, and thyroid disease) (odds ratio: 2.40 (P.value=0.028, CI 95% = 1.92-2.84) were significantly higher in deceased patients. The most common "1 < comorbidity" associated with mortality are Diabetic Mellitus and Ischemic Heart Disease. The summary of factors potentially influencing the mortality is listed in table 3. However, there is still no exclusive consensus on the role of vitamin D and mortality in COVID-19. In our study, we did not show a negative relationship between total mortality and mean levels of vitamin D. However, similar to previous studies, we revealed that in patients with severe disease the vitamin D deficiency was significantly correlated with mortality. Besides, in patients with a very low level of vitamin D, the mortality rate was higher. Eventually, we illustrated the pre-existing comorbidity, old age, male sex as a risk factor of higher mortality which was in line with previous studies. It is noteworthy that, vitamin D deficiency is a major public health problem worldwide in all age groups which considerably deteriorates with age that is important concerning COVID-19 as case-fatality rates surge with age (36) . Overall, in this retrospective study, we observed the relationship between the deficit of vitamin D and COVID-19 severity and mortality. Although there are still some limitations as a low sample size of our study which hampers the decisive conclusion. Additionally, we did not adjust other factors that can affect the severity of the disease along with vitamin D deficiency as old age and pre-existing comorbidity. Despite these limitations, our work is unique as it is the first article in Iran on the status of vitamin D in patients with COVID-19 and It has also been shown that in patients with high severity of onset, vitamin D deficiency can be a risk factor for increased mortality. Taking all considerations into account, apart from the prophylactic effect of vitamin D, regarding the importance of quarantine at home during the COVID-19 era, it is in paramount of importance to consider the bone metabolism health which relays on vitamin D supplementation, exposure to sunlight, and exercise. In this study, we did not reveal a statistical difference in mean levels of vitamin D and the outcome of patients with COVID-19. However, we concluded that in patients with severe disease, vitamin D deficiency could affect the course of the disease and mortality. Additionally, we identified older age, male gender, and pre-existing comorbidities as other contributing factors of higher mortality. New SARS-like virus in China triggers alarm China Novel Coronavirus I, Research T (2020) A novel coronavirus from patients with pneumonia in China The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? International journal of epidemiology Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection Clinical features of patients infected with 2019 novel coronavirus in Wuhan Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious Diseases Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges Potential interventions for novel coronavirus in China: a systemic review Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia Translating the role of vitamin D3 in infectious diseases Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess Vitamin D and influenza. Advances in nutrition High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis. Iranian journal of medical sciences Clinical management of severe acute respiratory infection when novel coronavirus ( 2019-nCoV) infection is suspected: interim guidance Viral dynamics in mild and severe cases of COVID-19. The Lancet Infectious Diseases Hossein-nezhad A, Holick MF. Optimize dietary intake of vitamin D: an epigenetic perspective. Current Opinion in Clinical Nutrition & Metabolic Care Which circulating level of 25-hydroxyvitamin D is appropriate? The Journal of steroid biochemistry and molecular biology Vitamin D and cardiovascular disease The association of vitamin D deficiency and incident frailty in older women: the role of cardiometabolic diseases Vitamin D deficiency as the risk of respiratory tract infections in the institutionalized elderly: A prospective 1-year cohort study Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. American journal of respiratory and critical care medicine Covid-19 in critically ill patients in the Seattle region-case series Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data Vitamin D deficiency: a factor in COVID-19, progression, severity and mortality?-An urgent call for research The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality Vitamin D insufficiency is prevalent in severe COVID-19. medRxiv Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation? The authors would like to thank the Labbafinejad Clinical Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran for the support, cooperation, and assistance throughout this study.